Sodium Glucose Transporter 2 Inhibitors Versus Metformin on Cardiovascular and Renal Outcomes in Patients With Diabetes With Low Cardiovascular Risk: A Nationwide Cohort Study

Sodium Glucose Transporter 2 Inhibitors Versus Metformin on Cardiovascular and Renal Outcomes in Patients With Diabetes With Low Cardiovascular Risk: A Nationwide Cohort Study

Background This study investigated whether initial SGLT2 (sodium‐glucose cotransporter 2) inhibitor‐based treatment is superior to metformin‐based regimens as a primary prevention strategy among low‐risk patients with diabetes. Methods and Results In this nationwide cohort study, a total of 38 496 p...

Full description

Bibliographic Details
Main Authors: Hao‐Chih Chang, Yun‐Yu Chen, Tzu‐Ting Kuo, Yenn‐Jiang Lin, Kuo‐Liong Chien, Hung‐Yu Chang, Chung‐Lieh Hung, Fa‐Po Chung
Format: Article
Language:English
Published: Wiley 2024-04-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
low cardiovascular risk
metformin
sodium‐glucose cotransporter 2 inhibitors
type 2 diabetes
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.123.032397

Similar Items

Similar Items